SCHEMBL6428739

SCHEMBL6428739

CC(=O)Oc1ccc(CC(C)(Cl)Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
ELANE P08246 3/20 0.47
MAPT P10636 3/20 0.46
POLB P06746 2/20 0.46
PKM P14618 1/20 0.46
HSD17B10 Q99714 1/20 0.43
ESR1 P03372 1/20 0.42
PGR P06401 1/20 0.42
CHRM2 P08172 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
AR P10275 1/20 0.42
CHRM1 P11229 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
GAA P10253 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HSP90AA1 P07900 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
CYP3A4 P08684 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12556696 0.85 LMNA (0.53) LMNAELANEMAPTPOLBPKM
SCHEMBL5733364 0.82 LMNA (0.50) LMNAELANEMAPTPOLBPKM
SCHEMBL29299436 0.81 LMNA (0.46) LMNAELANEMAPTPOLBPKM
SCHEMBL11053496 0.79 LMNA (0.47) LMNAELANEMAPTPOLBPKM
SCHEMBL22033169 0.78 BLM (0.63) LMNAELANEMAPTPOLBPKM
SCHEMBL22033171 0.78 BLM (0.63) LMNAELANEMAPTPOLBPKM
SCHEMBL80532 0.77 LMNA (0.57) LMNAELANEMAPTPOLBPKM
SCHEMBL8491271 0.77 MAPT (0.49) LMNAELANEMAPTPOLBPKM
SCHEMBL5567657 0.77 ACACB (0.45) LMNAELANEMAPTPOLBPKM
SCHEMBL9081470 0.77 LMNA (0.61) LMNAELANEMAPTPOLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1387822-B1 2-[4-(2,2,-DIHALOCYCLOPROPYL)PHENOXY]-ALKANOIC ACIDS AND ESTERS THEREOF PRODUCTION PROCESS LABORATORIO CHIMICO INT SPA (IT) 2005-06-15 EP disclosed
US-20050008687-A1 Metal-porphyrin-complex-embedded liposomes, production process thereof, and medicines making use of the same MAKOTO YUASA (JP) 2005-01-13 US disclosed
EP-1387822-A1 2-[4-(2,2,-DIHALOCYCLOPROPYL)PHENOXY]-ALKANOIC ACIDS AND ESTERS THEREOF PRODUCTION PROCESS LABORATORIO CHIMICO INTERNAZIONALE S.p.A. (IT) 2004-02-11 EP disclosed
WO-2002090307-A1 2-[4-(2, 2-DIHALOCYCLOPROPYL)PHENOXY]-ALKANOIC ACIDS AND ESTERS THEREOF PRODUCTION PROCESS LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) 2002-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050008687-A1 Metal-porphyrin-complex-embedded liposomes, production process thereof, and medicines making use of the same GPX4, FECH, PPOX LMNA 3056/4885ELANE 3229/4885MAPT 3457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.